Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$2.1 - $6.37 $209,353 - $635,038
99,692 New
99,692 $350,000
Q3 2022

Nov 14, 2022

SELL
$3.75 - $6.63 $139,361 - $246,390
-37,163 Reduced 72.45%
14,132 $87,000
Q2 2022

Aug 15, 2022

SELL
$2.11 - $4.06 $51,699 - $99,478
-24,502 Reduced 32.33%
51,295 $193,000
Q1 2022

May 16, 2022

BUY
$2.73 - $11.94 $206,925 - $905,016
75,797 New
75,797 $207,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.